Systemic control of HNF1B-driven redox homeostasis by N 6-adenosine methylation
Nucleic Acids Research · 2026
DOI: 10.1093/nar/gkaf1504 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2026. Verfasst von Minji Park und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 03822, Republic of Korea. Hauptthemen laut MEDLINE: Adenosine, Hepatocyte Nuclear Factor 1-beta. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Yuhan Corporation, KAIST.
Abstract (Originalsprache)
Transcription factors are key regulators of gene expression and play essential roles in various diseases, yet their lack of small-molecule binding pockets makes them difficult to target with drugs. Internal RNA modifications, such as N6-methyladenosine, are widespread in mammalian cells, but how m6A-encoded epitranscriptomic information influences transcription factor activity and cellular function remains incompletely understood. Here, we demonstrate that m6A methylation directly regulates HNF1B and is essential for maintaining redox homeostasis in cancer cells. The METTL3/METTL14 methyltransferase complex deposits m6A marks within the 3′-untranslated regions of HNF1B messenger RNA (mRNA), stabilizing its expression and function. Genetic or chemical inhibition of METTL3-mediated m6A modifications disrupts HNF1B-driven glutathione metabolism, severely impairing the antioxidant capacity of cancer cells and rendering them vulnerable to oxidative stress. Notably, HNF1B loss induces oxidative stress-induced cell death across multiple cancer lineages, mirroring the metabolic dysfunction caused by m6A depletion and establishing HNF1B as a central regulator of redox defense in human cancer. By directly linking RNA modifications of a transcription factor to redox homeostasis, our findings identify the METTL3-HNF1B axis as a metabolic vulnerability in cancer and highlight its potential as a target for m6A-directed cancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 03822, Republic of Korea.
- Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea.
- Department of Cell and Genetic Engineering, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
- Integrated Metabolomics Research Group, Western Seoul Center, Korea Basic Science Institute, Seoul 03760, Republic of Korea.
- College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.
ORCID-Profile: Dong-Myung Shin, Jae-Seok Roe
Förderung
- National Research Foundation of Korea
- Yuhan Corporation
- KAIST
- Korea Basic Science Institute
- Yonsei University
Zitieren
APA
Park, M., Kim, H. R., Park, J. H., Kim, Y., Shin, J. H., Lee, J., Ju, Y., Hwang, G. S., Shin, D. M., Kim, M. Y., & Roe, J. S. (2026). Systemic control of HNF1B-driven redox homeostasis by N 6-adenosine methylation. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf1504
Vancouver
Park M, Kim HR, Park JH, Kim Y, Shin JH, Lee J, et al. Systemic control of HNF1B-driven redox homeostasis by N 6-adenosine methylation. Nucleic Acids Research. 2026. doi:10.1093/nar/gkaf1504
BibTeX
@article{Park2026,
author = {Park, Minji and Kim, Hwa-Ryeon and Park, Ji Hoon and Kim, YongHwan and Shin, June-Ha and Lee, Jueun and Ju, Yeajin and Hwang, Geum-Sook and Shin, Dong-Myung and Kim, Mi-Young and Roe, Jae-Seok},
title = {Systemic control of HNF1B-driven redox homeostasis by N 6-adenosine methylation},
journal = {Nucleic Acids Research},
year = {2026},
doi = {10.1093/nar/gkaf1504}
}
EUVIMED